Eiry Roberts - 05 Jun 2025 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Reporting relationship: Director
Issuer ticker: FOLD
Reported as of: 05 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Jun 2025, 16:53:23 UTC
Prior SEC filing: 14 Feb 2025
Next SEC filing: 27 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Christian Formica, Attorney-in-Fact

Key filing fact

Eiry Roberts filed Form 4 for AMICUS THERAPEUTICS, INC. (FOLD) on 06 Jun 2025.

Key facts

This page summarizes Eiry Roberts's Form 4 filing for AMICUS THERAPEUTICS, INC. (FOLD).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 06 Jun 2025, 16:53.

Change

Previous filing in this sequence was filed on 14 Feb 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001727606 Primary reporting owner

ROBERTS EIRY

Relationship: Director
Address: 47 HULFISH STREET, PRINCETON
Signature: /s/ Christian Formica, Attorney-in-Fact
Signature date: 06 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FOLD transaction

Common Stock

Award

Transaction value: $0
Shares: +20,414
Change %: +37%
Price: $0.000000
Shares after: 76,275
Date: 05 Jun 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

FOLD transaction Derivative

Stock Options (right to buy)

Award

Transaction value: $0
Shares: +74,872
Change %
Price: $0.000000
Shares after: 74,872
Date: 05 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 74,872
Exercise price: $5.96
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.

Footnote F2

One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant.